Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
47
-
Total 13F shares, excl. options
-
3.29M
-
Shares change
-
+491K
-
Total reported value, excl. options
-
$44.3M
-
Value change
-
+$5.76M
-
Put/Call ratio
-
749
-
Number of buys
-
26
-
Number of sells
-
-14
-
Price
-
$13.46
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2016
56 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2016.
XBiotech Inc. - Common Shares, no par value (XBIT) has 47 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.29M shares
of 30.8M outstanding shares and own 10.7% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (915K shares), VANGUARD GROUP INC (688K shares), STATE STREET CORP (268K shares), BlackRock Institutional Trust Company, N.A. (215K shares), NORTHERN TRUST CORP (212K shares), GEODE CAPITAL MANAGEMENT, LLC (143K shares), CADIAN CAPITAL MANAGEMENT, LP (140K shares), Bank of New York Mellon Corp (67.8K shares), BlackRock Investment Management, LLC (67K shares), and SCHWAB CHARLES INVESTMENT MANAGEMENT INC (57.1K shares).
This table shows the top 47 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.